I nformation on recent trends in the prevalence of type 1 and type 2 diabetes in the United States is limited. Imperatore et al 1 reported that the predicted increase in the number of youth living with type 1 and type 2 diabetes by the year 2050 would be primarily among youth of minority race/ethnic groups. Worldwide, from 1990 to 2008, the incidence of type 1 diabetes has been increasing by 2.8% to 4.0% per year, 2 similar to that observed in the United States 3 for both nonHispanic white (hereafter called white) and Hispanic youth. However, a recent report from Finland, with the world's highest incidence, suggested a possible leveling off of the increase from 2005-2011. 4 Due to the very low mortality among youth with type 1 diabetes in the United States, 5 an increase in the incidence of type 1 diabetes will likely result in an increase in prevalence. Type 2 diabetes is increasingly diagnosed in youth and now accounts for 20% to 50% of new-onset diabetes case patients, 6 disproportionately affecting minority race/ethnic groups. [7] [8] [9] Although few longitudinal studies have been conducted, it has been suggested that the increase in type 2 diabetes in youth is a result of an increase in the frequency of obesity in pediatric populations. 10 Obesity in youth has been increasing since the 1960s though recent data suggest a plateau.
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There are a limited number of population-based studies of youth-onset type 2 diabetes. Most have involved American Indians and Native Canadians and showed high prevalence. 7, 12, 13 Similarly, type 2 diabetes incidence rates rose among nonHispanic black (hereafter called black), Hispanic, and white children with insulin-treated, non-type 1 diabetes from 1994 to 2003. 14 We explored whether overall prevalence of type 1 and type 2 diabetes among US youth changed from 2001 15 to 2009 13 and whether it changed by sex, age, and race/ethnicity. Understanding changes in prevalence according to population subgroups is important to inform clinicians about care that will be needed for the pediatric population living with diabetes and may provide direction for other studies designed to determine the causes of the observed changes.
Methods
A SEARCH description has been published 16 as have previous prevalence 13 , 15 and incidence results. 17 We 
Statistical Analyses
Prevalence was expressed as cases of type 1 or 2 diabetes per 1000 youth pooled across all sites with 95% CIs. Statistical tests for trends used a 2-sided skew-corrected inverted score test assuming a binomial distribution. 21 Assuming a significance level of 5%, we had more than 90% power to detect a change in prevalence of 0.07 per 1000 youth for the overall population and of 0.12 per 1000 youth for subgroup analyses. To assess trends over time it is important to determine whether case patients were identified with the same completeness of ascertainment in both years. This was estimated for the 4 geographic-based sites using the capture-recapture method. 22 For each center, case patients were identified from multiple sources (from 13 to 41). A source was defined as any location from which case patients were reported. Matching across sources to identify potential duplicate records was performed at the center level using personal health identifiers. Once matching was accomplished, the sources were further grouped into 2 modes of ascertainment (clinicians and inpatient hospital system records). Using the number of duplicate and case patients unique to one or the other source allowed calculation of the total estimated case patients in the geographic region. 22 The percentage completeness of ascertainment for each site was taken as the number of observed case patients divided by the total estimated number from the capture-recapture method. Pooled estimates used a global logarithmic-linear model and maximum likelihood analysis 23 using SAS version 9.3 (SAS Institute Inc). The 95% CIs computed for the capture-recapture adjusted prevalence estimates account for the variation in the estimates. Approximately 20% of the study population was ascertained in membership-based sites where it was impossible to assess completeness of ascertainment using capturerecapture analyses due to the lack of independent sources of case patient ascertainment. race/ethnic, and sex subgroup evaluated except for youth age 0 through 4 years and American Indians, which were the 2 population subgroups with the lowest prevalence of type 1 diabetes in 2001 and 2009. The greatest prevalence increase was observed in those aged 15 through 19 years. The prevalence of type 2 diabetes was higher in both periods among those aged 15 through 19 years than among those aged 10 through 14 years and higher among females than among males; larger absolute increases were seen in these groups over time (P < .001, Table 2 ).
Results

Type 1 Diabetes
Type 2 Diabetes
Completeness of Case Ascertainment
The Representativeness of the SEARCH Population Table 5 shows that for race/ethnicity, age, parental educational attainment, and median household income, the proportional distribution for 2001 and 2009 was very similar to the US census for 2000 and 2010. Thus, we were satisfied that the study areas reasonably represented the US population. 15 and in this report are due to exclusion of 1 prior study site in both years (Hawaii) and continued data cleaning. Differences from 2009 previously published 
Discussion
Type 1 Diabetes
Over the 8-year period, the adjusted prevalence of type 1 diabetes increased 21.1% (95% CI, 15.6%-27.0%) among US youth. Increases were observed in both sexes; in white, black, Hispanic, and Asian Pacific Islander youth; and in those aged 5 years or older. Historically, type 1 diabetes has been considered a disease that affects primarily white youth; however, our findings highlight the increasing burden of type 1 diabetes experienced by youth of minority racial/ethnic groups as well.
Increases in the prevalence of type 1 diabetes could reflect increases in disease incidence, decreases in mortality, or both. Mortality due to diabetes in youth is low ( 
Type 2 Diabetes
We also report, to our knowledge, the only multiethnic data on changes in the prevalence of type 2 diabetes in youth. The prevalence of type 2 diabetes in 2009 among adolescents aged 10 through 19 years was 0.46 per 1000 or 0.046%, with highest prevalence in American Indians, followed by black, Hispanic, and Asian Pacific Islander youth, with lowest prevalence in white youth, a pattern that is almost the inverse of that seen in type 1 diabetes. Prevalence was somewhat lower than reported in fifth-to 12th-grade students in Ohio (0.08%, previously diagnosed type 2 diabetes), 32 although a higher proportion of black students were included in that study. It was also lower than the screening results in the Studies to Treat or Prevent Pediatric Type 2 Diabetes 33 (STOPP-T2D) involving eighth-grade students, which documented a 0.5% prevalence of elevated screening glucose levels; however, only a single screening test was used. Compared with our estimate of 0.46 per 1000, the reported prevalence among sixth graders in the HEALTHY study (0.2 per 1000) 34 was lower, as was prevalence among students in the Philadelphia schools (0.35 per 1000 overall 29 ), which also reported substantially lower race/ethnicity specific estimates (0.03 per 1000 white; 0.28 per 1000 black; and 0.05 per 1000 Hispanic youth). We showed that the overall prevalence of type 2 diabetes between 2001 and 2009 increased by 30.5% when adjusted for an increase in prevalence of type 2 diabetes in Pima Indian youth aged 10 through 19 years in both sexes, with the highest prevalence in females. In Pima, the estimated average annual increase ranged from 1.9% to 10%, whereas we estimated the average annual increase at 4.4% overall, similar to that seen among the Pima Indians. Studies in Europe 36, 37 indicate that type 2 diabetes remains rare in largely white populations, and 1 report showed no trend 38 ; however, we observed a significant prevalence increase in white youth. Although differences in obesity rates between US and European youth are likely contributors, the full explanation for these discrepancies deserves further study.
Several reasons for the increasing type 2 diabetes prevalence are possible. Most likely are real changes in population risk for type 2 diabetes, such as minority population growth, obesity, exposure to diabetes in utero, 39 and perhaps endocrinedisrupting chemicals. 40 Similarly, changing awareness of type 2 diabetes in youth leading to different diagnostic practices may have contributed to the increases. Our study has limitations and strengths. We only included youth with diagnosed diabetes, which will miss youth who may meet diagnostic criteria for type 2 diabetes if screened, although this is much less of a limitation for youth with type 1 diabetes. However, the number of undiagnosed cases of type 2 diabetes is likely to be small. 32, 34 We only included 2 years of data and rates may vary from year to year. Also, the last year of data was 2009, 5 years ago, so we are not able to comment on whether current prevalence has changed. There were relatively small numbers of youth in some groups by race/ethnicity (especially American Indian and Asian Pacific Islanders) making these estimates of changes in prevalence less precise. Our observation period was relatively short and further surveillance will produce better estimates of changes. Strengths of the study include large numbers of youth identified using consistent methods from 2 periods; the population-based nature of the study; the racial/ethnic composition of the populations, which was similar in distribution to the United States; and the ability to show that our findings were not overly influenced by changes in case ascertainment or in clinician's diagnostic patterns of diabetes type. The increases in prevalence reported herein are important because such youth with diabetes will enter adulthood with several years of disease duration, difficulty in treatment, 41 an increased risk of early complications, and increased frequency of diabetes during reproductive years, which may further increase diabetes in the next generation. 7 
Conclusions
Between 2001 and 2009 in 5 areas of the United States, there was an increase in the prevalence of both type 1 and type 2 diabetes among children and adolescents. Further studies are required to determine the causes of these increases.
